Severe bleeding as a result of platelet inhibition caused by floxacillin treatment for endocarditis Juliane Rau, MD, Mark Simon, MD, Michael Sander,

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

“Lead from the front”: Participative leadership

Ground glass opacity of the lung: The veil that needs lifting

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Phillip S. Naimo, MD, David McGiffin, MD, FRACS, Igor E

Cutoff for high-sensitivity cardiac troponin T is not arbitrary but according to usual clinical practice Hector Cubero-Gallego, MD, PhD, Maria Heredia,

The lord of the rings Antonio Miceli, MD, PhD

The variability of the mitral valve anatomy and terminology

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery M. Ranucci, D. Colella, E. Baryshnikova, U.

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Military surgeons just want to have fun

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: A.

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Living without lungs? Bilateral pneumonectomy and dual circulatory support: A step forward in the search for a total artificial lung Christian A. Bermudez,

Niv Ad, MD, Lawrence M. Wei, MD

Is endoluminal vacuum therapy “sponge worthy”?

Attachment disorder in thoracoabdominal surgery

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

The Ross procedure: Time to reevaluate the guidelines

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Functional tricuspid pathology: To treat or not to treat

Warfarin or aspirin after mitral valve repair: Why work harder?

The harder one looks, the more one finds

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

A. Hofer, S. Kozek-Langenecker, E. Schaden, M. Panholzer, H. Gombotz

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

The continuing challenge of congenital heart disease in China

Between a rock and a hard place

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

Preoperative PFTs: The answer is blowing in the wind

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

How do we follow up our patients

Journal changes and initiatives

Edward Y. Chan, MD, Michael J. Reardon, MD

Calpain inhibitors: The aspirin of the 21st century?

Deciding how much to pay for effective care

Presentation transcript:

Severe bleeding as a result of platelet inhibition caused by floxacillin treatment for endocarditis Juliane Rau, MD, Mark Simon, MD, Michael Sander, MD, PhD, Christian von Heymann, MD, PhD, DEAA The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 6, Pages e63-e65 (December 2013) DOI: 10.1016/j.jtcvs.2013.07.071 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Initial results of multiple electrode aggregometry (A-C) and platelet count (D) for the patient treated with high-dose floxacillin, amiodarone, and 100 mg aspirin. Reference ranges are as follows: Thrombin receptor–activating peptide (TRAP) test, 84-128 units; aspirin-sensitive patient identification (ASPI) test, 71-115 units; adenosine diphosphate (ADP) test, 57-113 units; and platelet count, 150-400 × 109 cells/L. AU, Arbitrary units. The Journal of Thoracic and Cardiovascular Surgery 2013 146, e63-e65DOI: (10.1016/j.jtcvs.2013.07.071) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions